Open AccessA Novel Mutation of the Beta Myosin Heavy Chain Gene Responsible for Familial Hypertrophic Cardiomyopathy
Author(s) -
Wang Juan,
Xu ShiJie,
Zhou Hua,
Wang LiJie,
Hu Bo,
Fang Fang,
Zhang XuMin,
Luo YiWei,
He XiaoYan,
Zhuang ShaoWei,
Li XinMing,
Liu ZhongMing,
Hu DaYi
Publication year - 2009
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.20520
Subject(s) - myh7 , hypertrophic cardiomyopathy , missense mutation , genetics , genetic heterogeneity , medicine , haplotype , mutation , genotyping , gene mutation , gene , phenotype , genotype , biology , gene isoform
Background Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disorder and shows high variability in genetic heterogeneity and phenotypic characteristics. The genetic etiology responsible for HCM in many individuals remains unclear. Objective This instigation was sought to identify novel genetic determinants for familial hypertrophic cardiomyopathy. Methods Six unrelated Chinese families with HCM were studied. For each of the 13 established HCM‐susceptibility genes, 3 to 5 microsatellite markers were selected to perform genotyping and haplotype analysis. The linked genes were sequenced. Results Haplotype analyses on candidate genetic loci revealed cosegregation of the gene β‐myosin heavy chain ( MYH7 ) with HCM in a single family. A novel double heterozygous missense mutation of Ala26Val plus Arg719Trp in MYH7 was subsequently identified by sequencing in this family and was associated with a severe phenotype of HCM. Conclusion The novel double mutation of Ala26Val plus Arg719Trp in MYH7 identified in a Chinese family highlights the remarkable genetic heterogeneity of HCM, which provides important information for genetic counseling, accurate diagnosis, prognostic evaluation, and appropriate clinical management. Copyright © 2009 Wiley Periodicals, Inc.